Intacs® is the trademark name for micro-thin prescription inserts that were previously used as a form of refractive surgery in the treatment of low levels of myopia or nearsightedness, but have recently received FDA approval for treatment of keratoconus.
Intacs are thin plastic, semi-circular rings inserted into the mid-layer of the cornea. When inserted in the keratoconus cornea, they flatten the cornea, changing the shape and location of the cone. The placement of Intacs remodels and reinforces the cornea, eliminating some or all of the irregularities caused by keratoconus in order to provide improved vision. This can improve uncorrected vision, however, depending on the severity of the KC, glasses or contact lenses may still be needed for functional vision.
Medical Director Dan B. Tran was the first surgeon in the world to combine the commercial use of IntraLase technology with intracorneal rings (Intacs) to treat patients with keratoconus; a disorder that leads to a loss of vision in young adults. With his expertise, Dr. Tran has been instrumental in mentoring other surgeons around the world about this treatment.